Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 30Terminated 9Active not recruiting 5Withdrawn 4Unknown 4Recruiting 4Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 22Nasopharyngeal Carcinoma 11Squamous Cell Carcinoma of Head and Neck 9Small Cell Lung Carcinoma 9Uterine Cervical Neoplasms 7Biliary Tract Neoplasms 6Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Cholangiocarcinoma 5Lung Neoplasms 4Head and Neck Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Nasopharyngeal Neoplasms 3Endometrial Neoplasms 3Ovarian Neoplasms 2Neoplasms 2NSCLC 2Esophageal Neoplasms 2Breast Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Triple Negative Breast Neoplasms 1Tongue Squamous Cell Carcinoma 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Solid Tumor Cancer 1Recurrence 1Rare Tumour 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Drug Therapy 2pembrolizumab 1cemiplimab 1Tissue Banks 1Pemetrexed 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Mesothelioma, Malignant × Cisplatin × Clear all
NCT07234058 2026-02-11

LAG-MAPS

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
126 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡